Lutim Pharma Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 12-12-2024
- Paid Up Capital ₹ 0.10 M
as on 12-12-2024
- Company Age 20 Year, 3 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 3.00 M
as on 12-12-2024
- Revenue -2.32%
(FY 2021)
- Profit 30.92%
(FY 2021)
- Ebitda -39.12%
(FY 2021)
- Net Worth 13.18%
(FY 2021)
- Total Assets -5.37%
(FY 2021)
About Lutim Pharma
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹3.00 M.
Rajeshwari Sharma and Manoj Sharma serve as directors at the Company.
- CIN/LLPIN
U51397UR2004PTC029085
- Company No.
029085
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
21 Sep 2004
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Uttarakhand
Industry
Company Details
- LocationDehradun, Uttarakhand
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Lutim Pharma?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rajeshwari Sharma  | Director | 21-Sep-2004 | Current |
| Manoj Sharma | Director | 08-Jun-2023 | Current |
Financial Performance of Lutim Pharma.
Lutim Pharma Private Limited, for the financial year ended 2021, experienced Minor drop in revenue, with a 2.32% decrease. The company also saw a substantial improvement in profitability, with a 30.92% increase in profit. The company's net worth Soared by an impressive increase of 13.18%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Lutim Pharma?
In 2021, Lutim Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Indian Overseas Bank Creation Date: 16 Mar 2022 | ₹3.00 M | Open |
How Many Employees Work at Lutim Pharma?
Lutim Pharma has a workforce of 34 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Lutim Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Lutim Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
